recommendations regarding the manufacturing of CRP-1 for Phase I and Phase II clinical trials? Nucleon is about to launch Phases I and II clinical trials for their first product CRP-1 (cell regulating protein-1) targeted at treating burns and kidney failure. Both clinical trials would be carried out on a small sample of volunteers lasting 6-12 months for Phase I and 1-2 years for Phase II and Nucleon has to decide how to proceed regarding the production of necessary CRP-1 as they do not have manufacturing
Premium Clinical trial Drug discovery Pharmaceutical industry
We discussed 17 topics regarding about biotechnology. The first topic is about the history of biotechnology. Biotechnology began 7000 BC. It is the application of scientific engineering principles to the processing of materials by biological agents to provide goods and services. It is also a technique that uses living organisms (or parts of organisms) to make or modify products‚ to improve plants or animals‚ or to develop microorganisms for specific uses. Karl Ereky is the one who coined biotechnology
Premium DNA
Nucleon Inc. Nucleon‚ Inc. is one of over 200 firms founded since the 1970s which are focused on developing biotechnological pharmaceuticals products. Biotechnology came about with the development in advances of molecular biology and immunology‚ hence the new field of R&D is called “biotechnology”. Nucleons first product is CRP-1 (cell regulation ein-1) and after several years of experimentation the time was ready for human clinical trials‚ which was not going to be an easy hurdle to get over
Premium Strategic management Patent Clinical trial
Recombinant DNA Technology How to Mess with DNA for Fun and Profit OR OR How to Make a Mouse Glow in the Dark What the heck is Recombinant DNA? Recombinant DNA is what you get when you combine DNA from two different sources. For example: Mouse + Human DNA Human + Bacterial DNA Viral + Bacterial DNA Human + (other) Human DNA (It’s sort of like Frankenstein-DNA!) Why Make Recombinant DNA? Recombinant DNA Technology May Allow Us To: • Cure or treat disease • Genetically modify
Premium DNA Molecular biology Escherichia coli
List of Biotech / Pharma Companies in Mumbai COMPANY AREA OF WORK ADDRESS PHONE STD (022) FAX (022) URL HR Contacts Email Aarti Drugs Ltd. Manufacturing pharmaceutical products. Office: Mahendra Industrial Estate‚ Ground Floor‚ Road No 29‚ Plot No. 109 – D‚ SION (East)‚ Mumbai. Plant: Plot No. N – 198‚ M.I.D.C.‚ Tarapur‚ Village – Pamtembhi‚ Taluka – Palghar‚ Dist. Thane – 401 506. 24019025 24073462 24070144 www.aartidrugs.com Mr. Sudhir Nichani‚ HR Manager admn@aartidrugs.com Aarti Industries Limited
Premium Mumbai
Introduction Nucleon‚ a small biotechnology start-up company is in the process of human trials for their first potential product‚ i.e.‚ CRP-1. Nucleon has to decide among several alternatives on producing CRP-1 for their long-term survival in the intensively competitive and high-stakes drug industry. Industry Analysis -Porter’s Five Forces The Pharmaceutical industry has several high entry barriers as shown in figure 1. Economies of scale‚ product differentiation‚ government policy and capital
Premium Marketing Pharmacology Steel
MOLECULAR FARMING INTRODUCTION Biotechnology in agriculture has two categories: 1. “Improvements” to existing livestock and crops‚ and 2. Development of entirely new uses for both animals and plants (biopharming). “Improvements"‚ include ‘input traits’ such as crops with extra resistance to insect attack‚ improved weed control‚ increase the plants tolerance to cold‚ drought and other environmental factor. Ex "Roundup ready" soya‚ "Starlite" corn‚ or "Frost-tolerant" tomatoes. WHY PLANTS
Premium Cell Gene Endoplasmic reticulum
Nucleon‚ Inc. Final Case Table of Contents I. Executive Summary……………………………………………………………………………………………………………………3 II. Strategy Identification……………………………………………………………………………………………………………..…4 ▪ Key Issues and Problems III. Strategy Evaluation…………………………………………………………………………………………………………………….4 ▪ Industry Analysis – Porter’s 5 Forces ▪ Market Positioning Graph (Figure 1) ▪ Competitor Analysis – VRIO (Table 1) IV. Strategic Option Development……………………………………..…………………………………………………………
Premium Clinical trial Drug discovery Pharmaceutical industry
“STATEMENT OF PURPOSE” I “ABHIJEET”‚ have completed Bachelor’s of Science (with subjects Microbiology‚ Zoology and Chemistry) from “AVANTHI DEGREE COLLEGE”‚ affiliated to “OSMANIA UNIVERSITY”‚ in Hyderabad‚ India. Being a Bachelor in Microbiology‚ focusing on three dimensional aspects of my subjects is a core value of mine‚ one that I bring to every assignment I come across. Many tasks during my academic period have rewarded me with the ability to work independently as well as polished my role
Premium Graduate school Bachelor's degree Postgraduate education
CURRICULUM VITAE Pawan Kumar Address: S/o Subhash Chand‚H.No. 940‚ Mandir colony‚Dhand‚Kaithal Mobile No.: +919991349009 || E-Mail:pwnbio@gmail.com Career Objective: To gain employment with a company or organization that offers me a consistently positive atmosphere to learn new technologies and implement them for the betterment of the business and to develop my technical and analytical skills. Professional & Educational Qualification: |DEGREE / COURSE |INSTITUTE
Premium Microsoft Windows XP Marital status